About us

Publications

2022 (total impact fac. 143.218 ave. 13.02)

Okano, M., Hirahara, K., Kiuchi, M., Onoue, M., Iwamura, C., Kokubo, K., Hishiya, T., Morimoto, Y., Ikehara, Y., Murakami, A., Ebihara, N., and Nakayama, T.: Inetrleukin-33-activated neuropeptide CGRP-producing memory Th2 cells cooperate with somatosensory neurons to induce conjunctival itch. Immunity 55(12):2352-2368.e7 (2022). (43.474)

Fujimoto, M., Yokoyama, M., Kiuchi, M., Hosokawa, H., Nakayama, A., Hashimoto, N., Sakuma, I., Nagano, H., Yamagata, K., Kudo, F., Manabe, I., Lee, E., Hatano, R., Onodera, A., Hirahara, K., Yokote, K., Miki, T., Nakayama, T., and Tanaka, T.: Liver group 2 innate lymphoid cells regulate blood glucose levels through IL-13 signaling and suppression of gluconeogenesis. Nat. Commun. 13:5408 (2022). (17.694)

Kokubo, K., Onodera, A., Kiuchi, M., Tsuji, K., Hirahara, K., and Nakayama, T.: Conventional and pathogenic Th2 cells in inflammation, tissue repair, and fibrosis. Front. Immunol. 13:945063 (2022). (8.787)

Iinuma, T.,* Kiuchi, M.,* Hirahara, K., Kurita, J., Kokubo, K., Yagyu, H., Yoneda, R., Arai, T., Sonobe, Y., Fukuyo, M., Kaneda, A., Yonekura, S., Nakayama, T., Okamoto, Y., and Hanazawa, T.: Single-cell immunoprofiling after immunotherapy for allergic rhinitis reveals functional suppression of pathogenic TH2 cells and clonal conversion. (*These authors contributed equally to this work) J. Allergy Clin. Immunol. 150(4):850-860.e5 (2022). (14.290)

Koyama-Nasu, R., Wang, Y., Hasegawa, I., Endo, Y., Nakayama, T., and Kimura, M. Y.: The cellular and molecular basis of CD69 function in anti-tumor immunity. Int. Immunol. 34(11):555-561 (2022). (5.071)

Shinoda, K., Suganami, A., Moriya, Y., Yamashita, M., Tanaka, T., Suzuki, A. S., Suito, H., Akutsu, Y., Saito, K., Shinozaki, Y., Isojima, K., Nakamura, N., Miyachi, Y., Shirasawa, H., Matsubara, H., Okamoto, Y., Nakayama, T., and Tamura, Y.: Indocyanine green conjugated phototheranostic nanoparticle for photodiagnosis and photodynamic therapy. Photodiagnosis Photodyn. Ther. 39:103041 (2022). (3.577)

Iwamura, C., Hirahara, K., Kiuchi, M., Ikehara, S., Azuma, K., Shimada, T., Kuriyama, S., Ohki, S., Yamamoto, E., Inaba, Y., Shiko, Y., Aoki, A., Kokubo, K., Hirasawa, R., Hishiya, T., Tsuji, K., Nagaoka, T., Ishikawa, A., Kojima, A., Mito, H., Hase, R., Kasahara, Y., Kuriyama, N., Tsukamoto, T., Nakamura, S., Urushibara, T., Kaneda, S., Sakao, S., Tobiume, M., Suzuki, Y., Tsujiwaki, M., Kubo, T., Hasegawa, T., Nakase, H., Nishida, O., Takahashi, K., Baba, K., Iizumi, Y., Okazaki, T., Kimura, M. Y., Yoshino, I., Igari, H., Nakajima, H., Suzuki, T., Hanaoka, H., Nakada, T., Ikehara, Y., Yokote, K., and Nakayama, T.: Elevated Myl9 reflects the Myl9-containing microthrombi in SARS-CoV-2-induced lung exudative vasculitis and predicts COVID-19 severity. Proc. Natl. Acad. Sci. USA 119(33):e2203437119 (2022). (12.779)

Kanno, T., Miyako, K., Nakajima, T., Yokoyama, S., Sasamoto, S., Asou, H. K., Ohara, O., Nakayama, T., and Endo, Y.: SCD2-mediated cooperative activation of IRF3-IRF9 regulatory circuit controls type I interferon transcriptome in CD4+ T cells. Front. Immunol. 13:904875 (2022). (8.787)

Wakai, K., Azuma, K., Iwamura, C., Maimaiti, M., Mikami, K., Yoneda, K., Sakamoto, S., Ikehara, S., Yamaguchi, T., Hirahara, K., Ichikawa, T., Nakayama, T., and Ikehara, Y.: The new preparation method for paraffin-embedded samples applying scanning electron microscopy revealed characteristic features in asthma-induced mice. Sci. Rep. 12(1):9046 (2022). (4.997)

Shinoda, K.,* Choe, A.,* Hirahara, K.,* Kiuchi, M., Kokubo, K., Ichikawa, T., Hoki, J. S., Suzuki, A. S., Bose, N., Appleton, J. A., Aroian, R. V., Schroeder, F. C., Sternberg, P. W., and Nakayama, T.: Nematode ascarosides attenuate mammalian type 2 inflammatory responses. (*These authors contributed equally to this work) Proc. Natl. Acad. Sci. 119(1):e2108686119 (2022). (12.779)

Onodera, A., Kiuchi, M., Kokubo, K., and Nakayama, T.: Epigenetic regulation of inflammation by CxxC domain-containing proteins. Immunol. Rev. 305 (1):137-151 (2022). (10.983)